The DDW Turning Science into Business Symposium will take place in the afternoon on Tuesday 4 November 2025 at the Francis Crick Institute, one of Europe's biggest biomedical labs, in London, UK. This is a half day conference.

Programme

• 12.30-1.15PM Registration
• 1.25-1.30PM Welcome

• 1.30-2.00PM Dr Daniil Bash, Lead Scientist at the Innovation Centre in Digital Molecular Technologies (iDMT), University of Cambridge

• 2.00-2.30PM Nikhil Gupta, Principal Scientist at the Cancer Research Horizons - AstraZeneca Functional Genomics Centre

Advancing Oncology Drug Discovery Through Pooled CRISPR Screening

• 2.30-3.00PM Lawrence Welch, Inside Sales Specialist, Nuclera

Unlocking Drug Targets: 48-Hour Production of Membrane Proteins, E3 Ligases, and Transcription Factors with eProtein Discovery

• 3.00-3.30PM Networking coffee break
• 3.30-4.00PM Chas Bountra, Pro-Vice-Chancellor for Innovation, Professor of Translational Medicine, Oxford University

Building an Ecosystem to Rival Boston or Stanford

• 4.00-4.30PM Dr Cathy Tralau-Stewart, Executive Director of The Milner Therapeutics Institute, University of Cambridge

Connecting academic research with industry to drive therapeutic discoveries

• 4.30- 5PM Professor Emma Mead, Chief Scientific Officer of the Alzheimer’s Research UK Oxford Drug Discovery Institute 

Innovations in Target Identification, Validation and Drug Discovery for Neurodegenerative Diseases

• 5.00- 5.25PM Panel discussion:

Technology, market forces and new ways of working   - the challenges facing drug discovery and how to overcome them

Exploring the opportunity and challenges in drug discovery across neuroscience, oncology, age-related diseases and more. It will ask how technology is impacting the process for drug discovery and how the industry is responding to culture-shifts related to new ways of working.

Joanne Taylor, SVP Research, Gain Therapeutics

Nadine Clemo, VP Global Program Leader, Apollo Therapeutics

Daniel Ives, CEO and Founder, Shift Bioscience

Dr Cathy Tralau-Stewart, Executive Director of The Milner Therapeutics Institute, University of Cambridge

•  5.25-5.30PM

Goodbye

Sponsor 

Coffee break sponsor